← Leaderboards
George Painter
Emory University
$5,213,437
Attributed
$5,213,437
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2015–20$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,213,437 · 2
By mechanism
N01$5,213,437 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Rafi Ahmed$104,632,759
- Michael Benatar$26,653,090
- David S Stephens$107,429,191
- Kathleen Maletic Neuzil$28,253,585
- Nadine Georges Rouphael$18,470,672
Others in their field
Top investigators on “Communicable Diseases”
- Jeffrey P Krischer · University Of South Florida$580,775,398
- Judith S. Currier · University Of California Los Angeles$277,419,428
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$240,302,862
- Melynda Holmes · Technical Resources Inc$231,847,503
- Lawrence Corey · Fred Hutchinson Cancer Center$228,424,910
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
Research focus
Communicable DiseasesPre-ClinicalTherapeutic DevelopmentDrug CandidateFutureInfectious Disease TreatmentInfluenza TherapeuticIn VitroIn VivoLeadMedical CountermeasurePathway InteractionsPharmaceutical ChemistryToxic EffectAdvanced DevelopmentChikungunyaSafetySeriesSmall MoleculeTherapeutic CandidateProduct DevelopmentResearch And DevelopmentStagingCovid-19
Grant awards (6)
Advanced Development of Medical Countermeasures for Infectious Diseases$51,953
N01 · FY2020 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases - COVID-19 Related Studies$51,953
N01 · FY2020 · AI · contact PI
Advanced Development of Medical Countermeasures for Infectious Diseases$1,637,319
N01 · FY2019 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$1,198,108
N01 · FY2017 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$1,188,575
N01 · FY2016 · AI · contact PI
Optimizing Lead Therapeutic Compounds Against Infectious Diseases$1,085,529
N01 · FY2015 · AI · contact PI